Corgenix gets worldwide rights to Chugai liver test
This article was originally published in Clinica
Executive Summary
Corgenix Medical has signed a technology agreement with Chugai Diagnostics Science, part of Chugai Pharmaceutical, gaining worldwide rights outside Japan to manufacture and market a microplate test that measures hyaluronic acid as a unique indicator of liver disease. International marketing of the test will be co-ordinated by Corgenix' UK subsidiary.